Skip to main content

Garlic supplementation prevents oxidative DNA damage in essential hypertension

Molecular and Cellular Biochemistry volume 275, pages 85–94 (2005)Cite this article

Abstract

Oxygen-free radicals and other oxygen/nitrogen species are constantly generated in the human body. Most are intercepted by antioxidant defences and perform useful metabolic roles, whereas others escape to damage biomolecules like DNA, lipids and proteins. Garlic has been shown to contain antioxidant phytochemicals that prevent oxidative damage. These include unique water-soluble organosulphur compounds, lipid-soluble organosulphur compounds and flavonoids. Therefore, in the present study, we have tried to explore the antioxidant effect of garlic supplementation on oxidative stress-induced DNA damage, nitric oxide (NO) and superoxide generation and on the total antioxidant status (TAS) in patients of essential hypertension (EH). Twenty patients of EH as diagnosed by JNC VI criteria (Group I) and 20 age and sex-matched normotensive controls (Group II) were enrolled in the study. Both groups were given garlic pearls (GP) in a dose of 250 mg per day for 2 months. Baseline samples were taken at the start of the study, i.e. 0 day, and thereafter 2 months follow-up. 8-Hydroxy-2′-deoxyguanosine (8-OHdG), lipids, lipid peroxidation (MDA), NO and antioxidant vitamins A, E and C were determined. A moderate decline in blood pressure (BP) and a significant reduction in 8-OHdG, NO levels and lipid peroxidation were observed in Group I subjects with GP supplementation. Further, a significant increase in vitamin levels and TAS was also observed in this group as compared to the control subjects. These findings point out the beneficial effects of garlic supplementation in reducing blood pressure and counteracting oxidative stress, and thereby, offering cardioprotection in essential hypertensives.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Dates JA: Antihypertensive agents and the drug therapy of hypertension. In: P.B. Molinoff, R.V. Ruddom (eds). Goodman Gilman’s. The Pharmacological Basis of Therapeutics, 9th edn., Mc-Graw Hill, New~York, 1996, pp 780–800

    Google Scholar 

  2. Williams GH: Hypertensive vascular diseases. In: K. Isselbacher, E. Braunwald, J.D. Wilson et~al. (eds). Harrison’s Principles of Internal Medicine, 14th edn., McGraw-Hills, New York, 1967, pp 1380–1394

    Google Scholar 

  3. Leuritzen CL: Hypertension and pregnancy. In: J. Rosenthal (ed). Arterial Hypertension, Pathogenesis, Diagnosis and Therapy, Springer Verlag, New York, 1982, pp 102–116

    Google Scholar 

  4. Raptis S: Hypertension and diabetes mellitus. In: J. Rosenthal (ed). Arterial Hypertension, Pathogenesis, Diagnosis and Therapy, Springer Verlag, New York, 1982, pp 93–100

    Google Scholar 

  5. Weschsler J, Bitschunert H: Hypertension and obesity. In: J. Rosenthal (ed). Arterial Hypertension Pathogenesis, Diagnosis and Therapy. Springer Verlag, New York, 1982, pp 62–78

    Google Scholar 

  6. Helmut S: Oxidative stress: from basic research to clinical applications. Am J Med 30: 3031S–3037S, 1991

    Google Scholar 

  7. Dhalla NS, Temsah RM, Natticaden T: Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655–673, 2000

    Google Scholar 

  8. Halliwell B: Oxidants and human diseases: Some new concepts. FASEB 5: 358–364, 1987

    Google Scholar 

  9. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants and the degenerative diseases of ageing. PNAS 90: 7915–7922, 1993

    Google Scholar 

  10. Tagami M, Yamagata K, Fujino H, Nara Y, Nakagawa K, Kubota A, Numano F, Yamori Y: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 22: 23–29, 1999

    Google Scholar 

  11. Lacy F, O’Connor D, Schmid-Schenbein G: Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291–303, 1998

    Google Scholar 

  12. Russo C, Olivieri O, Girelli D, Faccini G, Zennari LM, Lombardi S, Corrocher R: Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267–1271, 1998

    Google Scholar 

  13. Dample B, Harrison L: Repair of oxidative damage to DNA: Enzymology and biology. Ann Rev Biochem 63: 915–924, 1994

    Google Scholar 

  14. Halliwell B: Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Free Radic Res 22: 23–29, 1998

    Google Scholar 

  15. Birmhom HK: The production of DNA strand breaks in human leukocytes by superoxide anion. Proc Natl Acad Sci USA 82: 80–88, 1985

    Google Scholar 

  16. Kasai H: Analysis of a form of oxidative DNA damage, 8-hydroxy-2′ deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387: 146–163, 1997

    Google Scholar 

  17. Totter HR: Spontaneous cancer and its possible relationship to oxygen metabolism. Proc Natl Acad Sci USA 77: 1763–1767, 1980

    Google Scholar 

  18. Burdon RH, Allingana D, Gill V: Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation. Free Radic Res 21: 121–134, 1994

    Google Scholar 

  19. Feig DI, Loeb LA: Mechanisms of mutation by oxidative DNA damage, reduced fidelity of mammalian DNA polymerase. J Biochem 32: 4466–4473, 1993

    Google Scholar 

  20. Chaudhary AK, Nokubo M, Reddy GR, et~al.: Detection of endogenous malondialdehyde deoxy-guanosine adducts in human liver. Science 265: 1580–1582, 1994

    Google Scholar 

  21. EL Ghissassi F, Barbin A, Nair J, Bartsch H: Formation of 1N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem Res Toxicol 8: 278–283, 1995

    Google Scholar 

  22. Simic MG: Urinary biomarkers and the rate of DNA damage in carcinogenesis. Mutat Res 267: 277–290, 1992

    Google Scholar 

  23. Loft S, Vistisen K, Ewertz MT, Jonneland A, Overad K, Poulsen E: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretions in humans. Influence of smoking, gender and body mass index. Carcinogenesis 13: 2241–2247, 1992

    Google Scholar 

  24. Loft S, Deng XS, Tuo J: Experimental study of oxidative DNA damage. Free Radic Res 29: 525–539, 1993

    Google Scholar 

  25. Mo Jim Maki H, Sakiguchi M: Hydrolytic elimination of a mutagenic nucleotide 8-oxod GTP by human 18-KDa protein: sensitisation of nucleotide pool. Proc Soc Natl Acad Sci USA 89: 11021–11025, 1992

    Google Scholar 

  26. Shigenaga M, Gimeno C, Ames B: Urinary 8-hydroxy 2′-deoxyguano- sine as a biological marker of in vivo oxidative DNA damage. Proc Soc Natl Acad Sci USA 86: 9697–9701, 1989

    Google Scholar 

  27. Yeh Y-Y, Lijuan L: Cholesterol lowering effects of garlic extracts an organosulfur compounds: human and animal studies. J Nutr 131: 989S–993S, 2001

    Google Scholar 

  28. Koscielny J, Klussendorf D, Schmidt R, Radtke H, Siegel G, Kiesewetter H: Study of garlic extracts and fractions on cholesterol plasma levels and vascular reactivity in cholesterol-fed rats. J Nutr 131: 994S–999S, 2001

    Google Scholar 

  29. Spigelski D, Jones Peter JH: Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutr Rev 59: 236–241, 2001

    Google Scholar 

  30. Foushee DB, Ruffin J, Banerjee U: Garlic as a natural agent for the treatment of hypertension: A preliminary report. Cytobios 34: 145–152, 1982

    Google Scholar 

  31. Steiner M, Li W: Aged garlic as a modulator of cardiovascular risk factors: Adose finding study on the effects of AGE on platelet function. J Nutr 131: 980S–984S, 2001

    Google Scholar 

  32. Bordia A, Verma SK, Srivastava KC: Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients of coronary heart disease. Prostaglandins. Leuk Essential Fatty acids 58: 257, 1998

    Google Scholar 

  33. Prasad K, Lax dal VA, Yu M, Rancy BL: Antioxidant activity of allicin, an active principle in garlic. Mol Cell Biochem 148: 183, 1995

    Google Scholar 

  34. The Sixth Report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157: 2401–2445, 1997

    Google Scholar 

  35. Green LC, Wagner DA, Glagowski J, Skipper PL, Wishnak JS, Tannenbaum SR: Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126: 131–138, 1982

    Google Scholar 

  36. Boyde TRC, Rahmatullah M: Optimisation of conditions for colorimetric determination of citrulline using diacetyl monoxime. Anal Biochem 107: 424–431, 1980

    Google Scholar 

  37. Thurnham DI, Smith E, Flora SP: Concurrent liquid chromatographic assay of retinol, α-tocopherol, carotene, cryptoxanthin in plasma with tocopherol acetate as internal standard. Clin Chem 34: 377–381, 1988

    Google Scholar 

  38. Margolis SA, Paule RC, Ziegler RG: Ascorbic and dehydroascorbic acids measured in plasma preserved with dithiothreitol or metaphosphoric acid. Clin Chem 36: 1750–1755, 1990

    Google Scholar 

  39. Benzie FF, Strain JJ: Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Anal Biochem 239: 15–27, 1996

    Google Scholar 

  40. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 21: 77–89, 1968

    Google Scholar 

  41. Cheung K, Archibald AC, Robinson MF: Luminol-dependent chemiluminescence produced by PMNL’s stimulated by immune complex. Aust J Exp Biol Med Sci 62: 403–419, 1984

    Google Scholar 

  42. Clerc M, Peuchant E, Carbonneau MA, Sess D: Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin Chem 37: 1423–1429, 1991

    Google Scholar 

  43. Lahiri DK, Bye S, Nurnber JL, Hodes ME, Crisp M: A non-organic and non-enzymatic extraction method gives higher yield of genomic DNA from whole blood sample than do other methods tested. J Biochem Biophys Methods 25: 193–205, 1992

    Google Scholar 

  44. Maniatis T, Sambrook J, Fritch EF: Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp 6.3–6.4

    Google Scholar 

  45. Whetton PK: Epidemiology of hypertension. Lancet 344: 101–106, 1994

    Google Scholar 

  46. Silaqy CA, Neil HAW: A meta analysis of the effect of garlic on blood pressure. J Hypertens 12: 463–468, 1994

    Google Scholar 

  47. Siegel G, Nuck R, Schnalke F, Michel F: Molecular evidences for phytopharmacological K channel opening by garlic in human vascular smooth muscle cell membranes. Phytother Res 12: S149–S151, 1998

    Google Scholar 

  48. Suetsuna K: Isolation and characterization of angiotensin 1 converting enzyme inhibitor peptides derived from Allium sativum L (garlic). J Nutr Biochem 9: 415–419, 1998

    Google Scholar 

  49. Pedraza-Chaverri J, Tapia E, Medina Campus ON: Garlic prevents hypertension by chronic inhibition of nitric oxide synthesis. Life Sci 62: 71–72, 1998

    Google Scholar 

  50. Mc Intyre M, Hamilton CA, Rees DD, Reid JL, Dominiczac AF: Sex differences in the abundance of endothelial nitric oxide in a model of hypertension. Hypertension 30: 1517–1524, 1997

    Google Scholar 

  51. Vaziri ND, Ni Z, Ovesi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248–1254, 1998

    Google Scholar 

  52. Luscher TF: Imbalance between endothelium-derived relaxing and contracting factors: A new concept in hypertension. Am J Hypertens 4: 317–330, 1990

    Google Scholar 

  53. Gryglewski RJ, Palmer RMJ, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454–456, 1986

    Google Scholar 

  54. Salahudeen AK: Role of lipid peroxidation in H2O2-induced renal epithelial (LLK-PK) cell injury. Am J Physiol 268: F30–F38, 1995

    Google Scholar 

  55. Takabashi K, Nammour TRM, Fukunaga M, Ebert J, Murrow JD, Hoover RL, Badr K: Glomerular action of a free radical-generated novel prostaglandin, 8-epi prostaglandin, 8-epi-PGF2α in the rat: Evidence for interaction with thromboxane A2 receptors. J Clin Invest 90: 136–141, 1992

    Google Scholar 

  56. Lin PJ, Pearson PJ, Cartier R, Schaff HV: Superoxide anion mediates the endothelium-dependent contraction to serotonin by regenerated endothelium. Thorac Cardiovasc Surg 102: 378–385, 1991

    Google Scholar 

  57. Tesfamariam B, Cohen RA: Role of Superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am J Physiol 262: H1915–H1919, 1992

    Google Scholar 

  58. Vaziri ND, Wang XQ: cGMP-mediated negative feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 34: 1237–1241, 1999

    Google Scholar 

  59. Attri J, Dhawan V, Mahmood S, Pandhi P, Parwana HK, Nath R: Effect of vitamin C supplementation on oxidative DNA damage in an experimental model of lead-induced hypertension. Ann Nutr Metab 47: 294–301, 2003

    Google Scholar 

  60. Negishi H, Njelekela M, Ikeda K, Sagara M, Noguchi T, Kuga S: Assessment of in vivo oxidative stress in hypertensive rats and hypertensive subjects in Tanzania, Africa. Hypertens Res 23: 285–289, 2000

    Google Scholar 

  61. Inoue S, Kawanishi S: Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 371: 86–88, 1995

    Google Scholar 

  62. Kumar KU, Das UN: Are free radicals involved in the pathophysiology of human essential hypertension? Free Radic Res Commun 19: 59–66, 1993

    Google Scholar 

  63. Singal PK, Khaper N, Palace U, Kumar D: The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40: 426–432, 1998

    Google Scholar 

  64. Dhawan V, Jain S: Effect of garlic supplementation on oxidized low-density lipoproteins and lipid peroxidation in patients of essential hypertension. Mol Cell Biochem 166: 115–119, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Veena Dhawan

  2. Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Sanjay Jain

  3. Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Research Block B, IInd Floor, Chandigarh, 160012, India

    Veena Dhawan

Authors
  1. Veena Dhawan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjay Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Veena Dhawan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dhawan, V., Jain, S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem 275, 85–94 (2005). https://doi.org/10.1007/s11010-005-0824-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-0824-2

Keywords

  • essential hypertension
  • garlic
  • 8-hydroxy-deoxy-2′guanosine
  • oxidative stress
  • oxygen-free radicals